The cancer vaccines market was estimated to be US$ 5.68 Bn in 2021 and US$ xx Bn in 2023. It is expected to reach US$ 16.86 Bn by 2031 and record a CAGR of 11.5% until 2031. Developing personalized cancer vaccines, focusing on combination therapies, and growing investments in cancer vaccine research and development activities will likely remain key cancer vaccines market trends.

 Source: - The Insight Partner